Filing Details

Accession Number:
0000899243-20-031340
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-17 21:00:35
Reporting Period:
2020-11-13
Accepted Time:
2020-11-17 21:00:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754129 D. Justin Gover Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-11-13 39,060 $0.00 495,113 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-13 3,924 $0.00 499,037 No 4 M Direct
Ordinary Shares Disposition 2020-11-13 42,984 $10.01 456,053 No 4 S Direct
Ordinary Shares Acquisiton 2020-11-16 22,800 $0.00 478,853 No 4 M Direct
Ordinary Shares Disposition 2020-11-16 22,800 $10.02 456,053 No 4 S Direct
Ordinary Shares Acquisiton 2020-11-17 42,708 $0.00 498,761 No 4 M Direct
Ordinary Shares Disposition 2020-11-17 42,708 $10.03 456,053 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2020-11-13 39,060 $0.00 39,060 $0.00
Ordinary Shares Stock Options Disposition 2020-11-13 3,924 $0.00 3,924 $0.00
Ordinary Shares Stock Options Disposition 2020-11-16 22,800 $0.00 22,800 $0.00
Ordinary Shares Stock Options Disposition 2020-11-17 42,708 $0.00 42,708 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
166,917 2020-01-06 2021-03-15 No 4 M Direct
10 2020-02-15 2021-03-15 No 4 M Direct
144,117 2020-01-06 2021-03-15 No 4 M Direct
101,409 2020-01-06 2021-03-15 No 4 M Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 13, 2020.
  3. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2020.
  4. Represented by ADSs.
  5. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($120.1533 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.99 per ADS (or $10.08 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 16, 2020.
  7. The price reported in Column 4 is a weighted average price per ordinary share ($120.2065 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.49 per ADS (or $10.04 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  8. The price reported in Column 4 is a weighted average price per ordinary share ($120.3923 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.85 per ADS (or $10.07 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  9. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.33 U.S. Dollars as of November 17, 2020.